KLF6 and Hermansky-Pudlak syndrome: Therefore, investigation of the role of KLF6 may enable the identification of the underlying mechanism of not only pulmonary angiogenesis but also intrahepatic angiogenesis and liver fibrosis, and targeted KLF6 therapy may benefit HPS patients.